Human papillomavirus and cervical cancer behavioral surveillance in the US

Cancer

Volumn 113, Issue 10 SUPPL., 2008, Pages 3013-3030

  Tiro, Jasmin A ^a   Saraiya, Mona ^b   Jain, Nidhi ^b   Liddon, Nicole ^b   Cokkinides, Vilma ^c   Lai, Sue Min ^d   Breen, Nancy ^e   Wideroff, Louise ^e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Behavioral surveillance; Cervical cancer; Human papillomavirus; Papanicolaou test use

Indexed keywords

WART VIRUS VACCINE;

CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; RELIABILITY; REVIEW; SELF REPORT; SEXUAL BEHAVIOR; UNITED STATES; UTERINE CERVIX CANCER; WART VIRUS;

ADOLESCENT; ADULT; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; FEMALE; HEALTH PERSONNEL; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POPULATION SURVEILLANCE; REPRODUCIBILITY OF RESULTS; SEXUAL BEHAVIOR; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 56449091027     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23760     Document Type: Review

References (84)

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2004 Incidence and Mortality Web-based Report. Available at: www.cdc.gov/uscs Accessed on February 11, 2008.
2. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol. 2003;102:417-427.
3. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342-362.
4. U.S. Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. Available at: http://www.ahrq.gov/clinic/ 3rduspstf/cervcan/cervcanrr.htm Accessed on May 2, 2006.
5. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197:346-355.
6. Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007;197:340-345.
7. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1-24.
8. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007;57:7-28.
9. Lansky A, Sullivan PS, Gallagher KM, Fleming PL. HIV behavioral surveillance in the U.S.: a conceptual framework. Public Health Rep. 2007;122:16-23.
10. Greenberg RS, Daniel SR, Flanders WD, Eley JW, Boring JR. Medical Epidemiology. 2nd ed. Stamford, CT: Appleton & Lange; 1996.
11. Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Morb Mortal Wkly Rep. 2001;50:1-35.
12. Link BG, Northridge ME, Phelan JC, Ganz ML. Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status. Milbank Q. 1998;76:375-402.
13. Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer. 2007;31:157-181.
14. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2006;109:360-370.
15. Benard V, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998 2001. Obstet Gynecol. 2007;110:681-686.
16. Lawson HW, Lee NC, Thames SF, Henson R, Miller DS. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet Gynecol. 1998;92:745-752.
17. Benard VB, Eheman CR, Lawson HW, et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol. 2004;103:564-571.
18. Keeter S, Miller C, Kohut A, Groves R, Presser S. Consequences of reducing nonresponse in a large national telephone survey. Public Opin Q. 2000;64:125-148.
19. Council of American Survey Research Organizations. On the Definition of Response Rates: A Special Report of the CASRO Task Force on Completion Rates. Available at: http://www.casro.org/resprates.cfm Accessed on October 28, 2007.
20. The American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 4th ed. Lenexa, KS: American Association for Public Opinion Research; 2006.
21. Curtin R, Presser S, Singer E. Changes in telephone survey nonresponse over the past quarter century. Public Opin Q. 2005;69:87-98.
22. Tucker C, Brick JM, Meekins B. Household telephone service and usage patterns in the U.S. in 2004: implications for telephone samples. Presented at: annual Association for Public Opinion Research Conference, May 12-15, 2005, Miami, Florida.
23. Tourangeau R. Survey research and societal change. Annu Rev Psychol. 2004;55:775-801.
24. Link MW, Battaglia MP, Frankel MR, Osborn L, Mokdad AH. Reaching the U.S. cell phone generation: comparison of cell phone survey results with an ongoing landline telephone survey. Public Opin Q. 2007;71:814-839.
25. Gardner BR, Strickland MJ, Correa A. Application of the automated spatial surveillance program to birth defects surveillance data. Birth Defects Res A Clin Mol Teratol. 2007;79:559-564.
26. Hughes E, McCracken M, Roberts H, et al. Surveillance for certain health behaviors among states and selected areas - Behavioral Risk Factor Surveillance System, United States, 2004. MMWR Surveill Summ. 2006;55:1-124.
27. Coughlin SS, King J, Richards TB, Ekwueme DU. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev. 2006;15:2154-2159.
28. Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006;60:202-207.
29. Wingo PA, Howe HL, Thun MJ, et al. A national framework for cancer surveillance in the United States. Cancer Causes Control. 2005;16:151-170.
30. Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average risk adults. Med Care. 2005;43:939-944.
31. Kellerman SE, Herold J. Physician response to surveys. A review of the literature. Am J Prev Med. 2001;20:61-67.
32. Yeazel MW, Lindstrom Bremer KM, Center BA. A validated tool for gaining insight into clinicians' preventive medicine behaviors and beliefs: the preventive medicine attitudes and activities questionnaire (PMAAQ). Prev Med. 2006;43:86-91.
33. Puleo E, Zapka JG, Goins KV, et al. Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report. Eval Health Prof. 2005;28:310-327.
34. Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004;191:105-113.
35. Negoita S, Harrison JN, Qiao B, Ekwueme DU, Flowers LC, Khan AR. Distribution of treatment for HPV-associated gynecologic carcinomas prior to prophylactic vaccine. Cancer. 2008;113(10 suppl):2926-2935.
36. Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006;24:S52-S61.
37. Koutsky LA, Harper DM. Chapter 13: current findings from prophylactic HPV vaccine trials. Vaccine. 2006;24:S114-S121.
38. Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298:743-753.
39. Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance - United States, 2005. MMWR Surveill Summ. 2006;55:1-108.
40. Joseph D, Miller J, Wu X-C, et al. Understanding the burden of HPV-associated anal cancers in the United States. Cancer. 2008;113(10 suppl):2892-2900.
41. Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soc Prev Med. 2001;46:S03-S42.
42. Bolton P, Holt E, Ross A, Hughart N, Guyer B. Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Public Health Rep. 1998;113:521-526.
43. Czaja C, Crossette L, Metlay JP. Accuracy of adult reported pneumococcal vaccination status of children. Ann Epidemiol. 2005;15:253-256.
44. Fishbein DB, Willis BC, Cassidy WM, et al. Determining indications for adult vaccination: patient self-assessment, medical record, or both? Vaccine. 2006;24:803-818.
45. Zimmerman RK, Raymund M, Janosky JE, Nowalk MP, Fine MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine. 2003;21:1491.
46. Stokley S, Rodewald LE, Maes EF. The impact of record scattering on the measurement of immunization coverage. Pediatrics. 2001;107:91-96.
47. Bloom B, Dey AN, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2005. Vital Health Statistics 10. 2006;231:1-84.
48. Gordon TE, Zook EG, Averhoff FM, Williams WW. Consent for adolescent vaccination: issues and current practices. J School Health. 1997;67:259-264.
49. Kinsey AC, Pomeroy WB, Martin CE. Sexual Behavior in the Human Male. Philadelphia: WB Saunders;1948:1-804.
50. Kinsey AC, Pomeroy WB, Martin CE, Gebhard PH. Sexual Behavior in the Human Female. Philadelphia: WB Saunders; 1953:1-842.
51. Jaccard J, McDonald R, Wan CK, Guilamo-Ramos V, Dittus P, Quinlan S. Recalling sexual partners: the accuracy of self-reports. J Health Psychol. 2004;9:699-712.
52. Kauth MR, St. Lawrence JS, Kelly JA. Reliability of retrospective assessments of sexual HIV risk behavior: a comparison of biweekly, 3-month, and 12-month self-reports. AIDS Educ Prev. 1991;3:207-214.
53. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297:813-819.
54. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis. 1995;22:15-21.
55. Peterman TA, Lin LS, Newman DR, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis. 2000;27:446-451.
56. Weinhardt LS, Forsyth AD, Carey MP, Jaworski BC, Durant LE. Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practice. Arch Sex Behav. 1998;27:155-180.
57. Freeman HP, Wingrove BK. Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005.
58. Janerich DT, Hadjimichael OC, Schwartz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995;85:791-794.
59. Hewitt M, Devesa SS, Breen N. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med. 2004;39:270-278.
60. Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007;57:105-111.
61. Solomon D, Schiffman M, Castle P, Jeronimo J. Predicting the effect of successful HPV vaccination on existing U.S. cervical screening programs. Cancer. 2008;113(suppl).
62. Vernon SW, Briss P, Tiro JA, Warnecke RB. Some methodologic lessons learned from cancer screening research. Cancer. 2004;101:1131-1145.
63. Partin MR, Casey-Paal AL, Slater JS, Korn JE. Measuring mammography compliance: Lessons learned from a survival analysis of screening behavior. Cancer Epidemiol Biomarkers Prev. 1998;7:681-687.
64. Rakowski WA, Breen NL, Meissner HI, et al. Prevalence and correlates of repeat mammography among women aged 55-79 in the year 2000 National Health Interview Survey. Prev Med. 2004;39:1-10.
65. Stein AD, Lederman RI, Shea S. Reproducibility of the women's module of the Behavioral Risk Factor Surveillance System questionnaire. Ann Epidemiol. 1996;6:47-52.
66. Brownson RC, Jackson-Thompson J, Wilkerson JC, Kiani F. Reliability of information on chronic disease risk factors collected in the Missouri Behavioral Risk Factor Surveillance System. Epidemiology. 1994;5:545-549.
67. Warnecke RB, Sudman S, Johnson TP, O'Rourke D, Davis AM, Jobe JB. Cognitive aspects of recalling and reporting health-related events: Papanicolaou smears, clinical breast examinations, and mammograms. Am J Epidemiol. 1997;146:982-992.
68. Pasick RJ, Stewart S, Bird JA, D'Onofrio CN. Quality of data in multiethnic health surveys. Public Health Rep. 2001;116(suppl 1):223-243.
69. Crane LA, Kaplan CP, Bastani R, Scrimshaw SCM. Determinants of adherence among health department patients referred for a mammogram. Women Health. 1996;24:43-64.
70. Fiscella K, Holt K, Meldrum S, Franks P. Disparities in preventive procedures: comparisons of self-report and Medicare claims data. BMC Health Serv Res. 2006;6:122.
71. Vernon SW, Meissner HI, Klabunde CN, et al. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev. 2004;13:898-905.
72. Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer (Cancer Cytopathol). 2007;111:145-153.
73. Irwin K, Montano D, Kasprzyk D, et al. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States. Obstet Gynecol. 2006;108:397-409.
74. Jain N, Irwin KL, Montano D, et al. Family physicians' knowledge of genital human papillomavirus (HPV) infection and HPV-related conditions, United States, 2004. Fam Med. 2006;38:483-489.
75. Santelli JS, Lindberg LD, Abma J, McNeely CS, Resnick M. Adolescent sexual behavior: estimates and trends from 4 nationally representative surveys. Fam Plan Perspect. 2000;32:156-165.
76. Santelli JS, Abma J, Ventura S, et al. Can changes in sexual behaviors among high school students explain the decline in teen pregnancy rates in the 1990s? J Adolesc Health. 2004;35:80-90.
77. Shrier LA, Crosby R. Correlates of sexual experience among a national representative sample of alternative high school students. J School Health. 2003;73:197-200.
78. Zapka JG, Puleo E, Taplin SH, et al. Processes of care in cervical and breast cancer screening and follow-up - the importance of communication. Prev Med. 2004;39:81-90.
79. Jain N, Irwin K, Carlin L, Freeman C, Montano D, Kasprzyk D. Use of DNA tests for human papillomavirus infection by US clinicians, 2004. J Infect Dis. 2007;196: 76-81.
80. Saraiya M, Irwin KL, Carlin L, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer. 2007;110:1024-1032.
81. Binswanger IA, White MC, Perez-Stable EJ, Goldenson J, Tulsky JP. Cancer screening among jail inmates: frequency, knowledge, and willingness. Am J Public Health. 2005;95:1781-1787.
82. Hiatt RA, Klabunde CN, Breen NL, Swan J, Ballard-Barbash R. Cancer screening practices from National Health Interview Surveys: past present, and future. J Natl Cancer Inst. 2002;94:1837-1846.
83. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007;40:108-115.
84. Saraiya M, Goodman MT, Datta D, Chen VW, Wingo PA. Cancer registries and monitoring the impact of prophylactic HPV vaccines: potential role. Cancer. 2008;113(10 suppl):3047-3057.